OTC · CIK 0001792941
GNVR Genvor Inc
Insider trading from SEC Form 4. Last filing Apr 16, 2026.
Genvor Inc (GNVR) has 9 SEC Form 4 filings on file from 3 insiders, the latest filed on Apr 16, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
Last 90 days
Signals
Open-market buys and sells at Genvor Inc, scored.
Transactions
Every row filed, 16 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 15, 2026 | Chad Lee Pawlak Sr. Chief Executive Officer | AGrant or award Common Stock | +250,000 | $0.50 | $125k | 7,000,000 | Apr 16, 2026 |
| Apr 7, 2026 | Chad Lee Pawlak Sr. Chief Executive Officer | AGrant or award Common Stock | +250,000 | - | - | 6,750,000 | Apr 14, 2026 |
| Jan 9, 2026 | Chad Lee Pawlak Sr. Chief Executive Officer | AGrant or award Common Stock | +250,000 | - | - | 6,500,000 | Jan 9, 2026 |
| May 8, 2025 | Jessee M Jaynes Chief Research Officer | AGrant or award Common Stock | +400,000 | $0.25 | $100k | 400,000 | Dec 5, 2025 |
| Dec 2, 2025 | Jessee M Jaynes Chief Research Officer | AGrant or award Common Stock | +124,000 | $1.50 | $186k | 524,000 | Dec 5, 2025 |
| Oct 8, 2025 | Chad Lee Pawlak Sr. Chief Executive Officer | AGrant or award Common Stock | +250,000 | - | - | 6,250,000 | Oct 9, 2025 |
| Jul 1, 2025 | Chad Lee Pawlak Sr. Chief Executive Officer | AGrant or award Common Stock | +250,000 | - | - | 6,000,000 | Jul 3, 2025 |
| May 8, 2025 | Clayton Clopton Yates director, owner | AGrant or award Common Stockindirect: ACT Holdings, LLC10b5-1 | +400,000 | $0.25 | $100k | 400,000 | Jun 23, 2025 |
| Apr 17, 2024 | Chad Lee Pawlak Sr. Chief Executive Officer | AGrant or award Common Stock | +25,000 | - | - | 125,000 | Jun 20, 2025 |
| Apr 25, 2025 | Chad Lee Pawlak Sr. Chief Executive Officer | AGrant or award Common Stock | +250,000 | - | - | 375,000 | Jun 20, 2025 |
| Apr 25, 2025 | Chad Lee Pawlak Sr. Chief Executive Officer | AGrant or award Common Stock | +4,875,000 | - | - | 5,250,000 | Jun 20, 2025 |
| May 2, 2025 | Chad Lee Pawlak Sr. Chief Executive Officer | AGrant or award Common Stock | +500,000 | $0.25 | $125k | 5,750,000 | Jun 20, 2025 |
| Apr 17, 2024 | Chad Lee Pawlak Sr. Chief Executive Officer | AGrant or award Common Stock | +25,000 | - | - | 125,000 | Jun 18, 2025 |
| Apr 25, 2024 | Chad Lee Pawlak Sr. Chief Executive Officer | AGrant or award Common Stock | +25,000 | - | - | 375,000 | Jun 18, 2025 |
| Apr 25, 2024 | Chad Lee Pawlak Sr. Chief Executive Officer | AGrant or award Common Stock | +4,875,000 | - | - | 5,250,000 | Jun 18, 2025 |
| May 2, 2025 | Chad Lee Pawlak Sr. Chief Executive Officer | AGrant or award Common Stock | +500,000 | $0.25 | $125k | 5,750,000 | Jun 18, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Jessee M JaynesChief Research Officer
- Chad Lee Pawlak Sr.Chief Executive Officer
- Clayton Clopton Yatesdirector, owner
Questions about GNVR
Answered from the filings on this page, as of the latest one.
Are insiders buying GNVR?
No. In the last 90 days no insider at Genvor Inc bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade GNVR on the open market?
No open-market trade has been scored at Genvor Inc. The latest Form 4 on file was filed on Apr 16, 2026 and holds grants, exercises or other rows that are not market trades.
How many insiders file Form 4 at Genvor Inc?
3 people have filed a Form 4 at Genvor Inc, among them Jessee M Jaynes (Chief Research Officer), Chad Lee Pawlak Sr. (Chief Executive Officer), Clayton Clopton Yates (director and 10% owner). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.